RadNet Inc. (RDNT)
NASDAQ: RDNTHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 68.61 0.00%
RDNT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.40B
- Forward P/E
- 77.38
- EPS (TTM)
- -$0.27
- Dividend yield
- None
- 52-week range
- 50.82 – 85.84
- Day range
- 68.45 – 70.66
- Volume / Avg
- 398.60K / 715.70K
- Beta
- —
- Shares outstanding
- 78.70M
52-week range
RDNT stock today
Shares of RadNet (RDNT) finished lower on Oct 7 at $68.61, a drop of 2.38% or $1.67 per share, versus the S&P 500's 0.22% decline. At this level, RDNT sits in the middle of its 52-week range of $50.82 to $85.84: 20.1% below the high, set on Nov 25, 2025 and 35.0% above the low. RDNT is down 2.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 11.1%.
RadNet has posted a net loss over the last twelve months (EPS of -$0.27), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About RadNet
Company profileRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Dr. Howard G. Berger M.D.
- Headquarters
- Los Angeles, CA
- Employees
- 11,000
- Website
- radnet.com
Financial highlights
Full financialsIn fiscal 2025, RadNet generated $2.04 billion in revenue, up 11.5% from fiscal 2024, its 5th consecutive year of revenue growth. RadNet reported a net loss of $18.7 million, compared with net income of $2.8 million a year earlier. Operating margin was 3.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.04B | $1.83B | $1.62B | $1.43B | $1.32B |
| Growth | +11.51% | +13.18% | +13.05% | +8.74% | +22.69% |
| Net income | $-18.65M | $2.79M | $3.04M | $10.65M | $24.73M |
| EPS (diluted) | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 |
Analyst forecast
ForecastConsensus (8 analysts)
none
Avg. price target
$94.63+37.92%
- Strong buy 2
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Q2 2026)
- Aug 10, 2026
- EPS actual vs est.
- $0.10 vs —
RadNet peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GRALGRAIL Inc. | 132.90 | -3.19% | $5.94B | vs RDNT |
| CONConcentra Group Holdings Parent Inc. | 36.40 | 0.00% | $4.64B | vs RDNT |
| BLLNBillionToOne Inc. Class A | 95.75 | -4.19% | $4.52B | vs RDNT |
| VCYTVeracyte Inc. | 43.16 | -3.34% | $3.47B | vs RDNT |
| CAICaris Life Sciences Inc. | 27.10 | -1.29% | $7.66B | vs RDNT |
| CDNACareDx Inc. | 63.04 | -1.18% | $3.26B | vs RDNT |
| CELCCelcuity Inc. | 65.78 | -7.68% | $3.22B | vs RDNT |
| ACHCAcadia Healthcare Company Inc. | 29.23 | +0.65% | $2.72B | vs RDNT |
Indexes, lists and sector
RadNet stock FAQ
What is RadNet's stock price today?
RDNT last traded at $68.61 as of Oct 7, 4:00 PM EDT, down 2.38% on the day. Prices are delayed at least 15 minutes.
Does RadNet pay a dividend?
No. RadNet does not currently pay a regular cash dividend.
Who is RadNet's CEO?
Dr. Howard G. Berger M.D. is the chief executive officer of RadNet Inc., which has about 11,000 employees.
Has RDNT ever split its stock?
Yes. The most recent RDNT stock split was a 1-for-2 split on Nov 28, 2006.
What is the RDNT 52-week high?
The 52-week high for RDNT is $85.84 and the 52-week low is $50.82. The stock is currently 20.1% below its high.